Dual DDR1 and DDR2 inhibitor 5n, identified by its CAS number 2241813-33-0, is a chemical compound designed to inhibit the activity of the discoidin domain receptors (DDR1 and DDR2), which are involved in various cellular processes, including cell adhesion, migration, and proliferation. This compound is characterized by its specificity for these receptor tyrosine kinases, making it a potential candidate for therapeutic applications in diseases where DDR signaling is implicated, such as fibrosis and cancer. The structure of 5n typically includes functional groups that enhance its binding affinity and selectivity for DDR1 and DDR2. Additionally, its pharmacokinetic properties, such as solubility, stability, and bioavailability, are crucial for its effectiveness as a drug candidate. Research into this compound may also explore its mechanism of action, potential side effects, and efficacy in preclinical or clinical settings. Overall, Dual DDR1 and DDR2 inhibitor 5n represents a promising avenue for targeted therapy in conditions associated with aberrant DDR signaling.

Dual DDR1 and DDR2 inhibitor 5n

2241813-33-0: Dual DDR1 and DDR2 inhibitor 5n, identified by its CAS number 2241813-33-0, is a chemical compound designed to inhibit the activity of the discoidin domain receptors (DDR1 and DDR2), which are involved in various cellular processes, including cell adhesion, migration, and proliferation. This compound is characterized by its specificity for these receptor tyrosine kinases, making it a potential candidate for therapeutic applications in diseases where DDR signaling is implicated, such as fibrosis and cancer. The structure of 5n typically includes functional groups that enhance its binding affinity and selectivity for DDR1 and DDR2. Additionally, its pharmacokinetic properties, such as solubility, stability, and bioavailability, are crucial for its effectiveness as a drug candidate. Research into this compound may also explore its mechanism of action, potential side effects, and efficacy in preclinical or clinical settings. Overall, Dual DDR1 and DDR2 inhibitor 5n represents a promising avenue for targeted therapy in conditions associated with aberrant DDR signaling.

<p>DDR1/2 inhibitor-3 (5n) is an inhibitor of DDR1/2, with IC50 values of 9.4 nM and 20.4 nM, respectively. It is applicable in anti-inflammatory research.</p>

CAS 2241813-33-0

Dual DDR1 and DDR2 inhibitor 5n

DDR1/2 inhibitor-3

Ref: TM-T204457